Back to results
US 12,421,233 B2Granted
WRN inhibitors
AssigneeNimbus Wadjet, Inc.
InventorsDerun Li, Angela V. West, Justin Caravella, Nathan E. Genung, Florian Bartels, Robert Lee Dow, Silvana Marcel Leit de Moradei, Nikolay Sitnikov
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to compounds of Formula I: and pharmaceutically acceptable salts thereof, and compositions thereof, as well as methods of treatment of cancers such as those involving WRN protein.
Claims20
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising a pharmaceutically acceptable carrier, adjuvant, or vehicle and a compound selected from the group consisting of:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.